Selected article for: "report case and true prevalence"

Author: Crocetta, Francesco Maria; Botti, Cecilia; Fornaciari, Martina; Castellucci, Andrea; Murri, Domenico; Santandrea, Giacomo; Piana, Simonetta; Ghidini, Angelo
Title: Sinonasal NUT Carcinoma: Delayed Diagnosis Due to the COVID-19 Pandemic and a Review of the Literature
  • Cord-id: de338lm5
  • Document date: 2021_3_8
  • ID: de338lm5
    Snippet: NUT carcinoma (NUT-C) is a relatively new malignancy that was recently listed in the 4th edition of the WHO Classification of Head and Neck Tumors in 2017. NUT carcinoma is a rare, aggressive, poorly differentiated carcinoma genetically defined by chromosomal rearrangement of the nuclear protein in testis (NUTM1) gene. The prognosis is extremely poor, with a mean survival < 1 year. Recent publications suggest a multimodality treatment approach. In the existing literature, only a few reports of s
    Document: NUT carcinoma (NUT-C) is a relatively new malignancy that was recently listed in the 4th edition of the WHO Classification of Head and Neck Tumors in 2017. NUT carcinoma is a rare, aggressive, poorly differentiated carcinoma genetically defined by chromosomal rearrangement of the nuclear protein in testis (NUTM1) gene. The prognosis is extremely poor, with a mean survival < 1 year. Recent publications suggest a multimodality treatment approach. In the existing literature, only a few reports of sinonasal NUT-C have been reported. Sinonasal NUT-C is considered a very rare entity, but because of its recent inclusion as a head and neck malignancy, its true prevalence is unknown. We report the case of a 56-year-old woman with NUT-C of the sinonasal cavities. In the case reported, the coexistence of Coronavirus disease 2019 (COVID-19)-related nasal congestion delayed the diagnosis of NUT-C. Clinical presentation, diagnosis and treatment modalities are discussed together with a review of the literature.

    Search related documents:
    Co phrase search for related documents
    • adjuvant treatment and local recurrence: 1, 2, 3, 4, 5, 6
    • adjuvant treatment and locally advanced: 1, 2, 3
    • adjuvant treatment and locally advanced disease: 1
    • adjuvant treatment and lymph node: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • adjuvant treatment and magnetic resonance: 1, 2
    • adjuvant treatment consider and lymph node: 1
    • admission week and locally advanced: 1
    • admission week and lymph node: 1
    • admission week and magnetic resonance: 1, 2, 3
    • local invasion and lymph node: 1, 2
    • local recurrence and lymph node: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
    • local recurrence and magnetic resonance: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • locally advanced and lymph node: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • locally advanced and magnetic resonance: 1, 2, 3, 4, 5
    • locally advanced disease and lymph node: 1, 2
    • locally advanced disease and magnetic resonance: 1
    • low grade fever and lymph node: 1
    • low grade fever and magnetic resonance: 1
    • lymph node and magnetic resonance: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18